BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
5.90
+0.10 (1.72%)
Dec 22, 2024, 10:44 AM IDT
BioLineRx Revenue
BioLineRx had revenue of $4.94M USD in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $21.99M. In the year 2023, BioLineRx had annual revenue of $4.80M.
Revenue (ttm)
$21.99M
Revenue Growth
n/a
P/S Ratio
0.96
Revenue / Employee
$278.37K
Employees
79
Market Cap
82.79M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBioLineRx News
- 27 days ago - BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - BioLineRx GAAP EPS of $0.00 beats by $0.07, revenue of $4.94M misses by $0.35M - Seeking Alpha
- 27 days ago - BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value - PRNewsWire
- 27 days ago - Earnings Scheduled For November 25, 2024 - Benzinga
- 4 weeks ago - BioLineRx Q3 2024 Earnings Preview - Seeking Alpha
- 4 weeks ago - BioLineRx inks licensing deal, share purchase agreement - Seeking Alpha
- 4 weeks ago - BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. - PRNewsWire
- 4 weeks ago - BioLineRx to Report Third Quarter 2024 Results on November 25, 2024 - PRNewsWire